Michael D. Hooven, Director at AtriCure, Inc. (ATRC), sold 17,065 shares at $8.10 ($135K) on 2010-11-10, disclosed to the SEC on 2010-11-12.
Open-market sale of $135k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 429 | $0 | 0.0% |
| 2 | $8.10 | 8,157 | $66K | 49.0% |
| 3 | $8.10 | 8,479 | $69K | 51.0% |
| Total | $7.90 avg | 17,065 | $135K | 100% |
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |